{
    "nct_id": "NCT05842174",
    "official_title": "Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional Therapy",
    "inclusion_criteria": "* Male or female, aged 18 years, meeting criteria for diagnosis of BCLC B HCC and referred to undergo TACE\n* HCC measuring 3 cm in minimum transverse diameter and meets LI-RADS 5 criteria based on cross-sectional imaging as determined by a board-certified, sub-specialty trained radiologist\n* Childs Pugh Turcotte A/B7, Performance Status 0\n* Informed of investigational nature of this study with provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* QT prolongation on ECG\n* Retinopathy on ophthalmologic examination\n* Females who are pregnant or breast feeding at the time of screening will not be eligible for this study\n\n  * a serum or urine pregnancy test will be performed in women of child-bearing potential at screening\n* Prior LRT or systemic therapy to the target lesion\n* Contraindication to contrast enhanced MRI or metallic implant within the liver.\n* HCQ allergy, porphyria, uncontrolled psoriasis, and existing retinopathy\n* Lesion not amenable to biopsy based on pre-TACE imaging as determined by treating interventional radiologist\n* Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study)",
    "miscellaneous_criteria": ""
}